Home›Companies›Healthcare›Ostentus Therapeutics

Ostentus Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 8, 2024·Suggest an edit

About Ostentus Therapeutics

Ostentus Therapeutics is a private company based in Newport Coast, California, incorporated in 2021 in California. It has reported $1,757,500 raised in five offerings on Form D since December 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 24, 2024Mar 8, 2024$150,000of $9.8M target2$75,000EquityRule 506(c)Form D ↗
Oct 4, 2022Oct 13, 2022$520,000of $770K target7$74,286EquityRule 504Form D ↗
Sep 28, 2022Oct 6, 2022$487,500fully sold4$121KEquityRule 504Form D ↗
Jan 25, 2022Jan 26, 2022$100,000of $7.5M target1$100KEquityRule 506(c)Form D ↗
Dec 13, 2021Dec 23, 2021$500,000fully sold5$100KEquityRule 504Form D ↗
Total, five offerings$1,757,500

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ostentus Therapeutics's Form D filed Mar 8, 2024.

WG
William Graff
Director and promoter
EG
Elisabetta Graff
President and director
SW
Stuart Weinstein
Director and promoter

Sources

  1. SECOstentus Therapeutics, Inc. filing history